Biosynthesis of isoxazolin-5-one and 3-nitropropanoic acid containing glucosides in juvenile Chrysomelina

Abstract

Stable-isotope-labeled precursors were used to establish the biosynthetic pathway leading from β-alanine towards isoxazolin-5-one glucoside 1 and its 3-nitropropanoate (3-NPA) ester 2 in Chrysomelina larvae. Both structural elements originate from sequestered plant-derived β-alanine or from propanoyl-CoA that is derived from the degradation of some essential amino acids, e.g. valine. β-Alanine is converted into 3-NPA and isoxazolinone 5 by consecutive oxidations of the amino group of β-Ala. Substituting the diphospho group of α-UDP-glucose with 5 generates the isoxazolin-5-one glucoside 1, which serves in the circulating hemolymph of the larva as a platform for esterification with 3-nitropropanoyl-CoA. The pathway was validated with larvae of Phaedon cochleariae, Chrysomela populi as well as Gastrophysa viridula.

---

Introduction

Leaf beetles of the subtribe Chrysomelina^1–8 and a number of legume plants^9–12 produce the glucosides 1 and 2 (Fig. 1). The latter serves as a pre-toxic storage compound for the actual poison 3-nitropropanoic acid (3-NPA). 3-NPA derived compounds provide a second defensive line in Chrysomelina, parallel with and independent of larval defensive secretions released from nine paired dorsal glands.^13,14

Fig. 1 Isoxazolin-5-one glucosides in Chrysomelina larvae.

Free 3-NPA was found in low concentration in the hemolymph of Chrysomelina, but was observed in significant amounts in adult secretions of these beetles as well as in some plants, e.g. Corynocarpus laevigatus, and fungi, for example in Penicillium atrovenetum.^15–19 The toxic effect of this compound is due to its isoelectronic character to succinic acid, leading to a covalent addition product with mammalian succinate dehydrogenase.^20,21 Thus, mitochondrial respiration is inhibited in these animals. As this effect is most relevant to nerve cells²² significant economic damage is caused to cattle feeding on 3-NPA containing food plants.²³

Aspects of the biosynthesis of 3-NPA have been characterized in Penicillium atrovenetum using stable-isotope-labelled precursors, e.g. [2-¹³C,¹⁵N]-asp and ¹⁸O₂.^17,18,24 In plants, the biosyntheses of isoxazolin-5-one derivatives (glucosides and non-glucosides)^9,25,26 as well as of the 3-NPA moiety^24,27 have been examined using ¹⁴C-labeled compounds or with in vitro assays. In Indigofera spicata 3-NPA derives from malonate and malonyl monohydroxamate.²⁷ The biosynthesis might involve β-alanine as an intermediate.²⁸

Adult leaf beetles of Chrysomela tremulae feeding on host plant leaves impregnated with [¹⁴C₄]-aspartate demonstrated incorporation of radioactivity into compounds 1 and 2.⁸ This experiment indicates the ability for de novo production of compounds 1 and 2 in Chrysomelina. Since no evidence was provided for any suggested intermediate, a contiguous metabolic pathway for the biosynthesis of compounds 1 and 2 in Chrysomelina leaf beetles has not yet been elucidated.^6,8

Results and discussion

Along with previous identifications of 3-NPA in the defensive secretions of adult leaf beetles^6,8 the first biosynthetic experiments with [¹⁴C₄]-aspartate were published claiming aspartate as the ultimate precursor.⁸ As shown in Fig. 2, feeding of [¹³C₄¹⁵N]-Asp, surface-impregnated on leaves of B. rapa pekinensis and fed to larvae of Phaedon cochleariae (see Experimental) results in a cluster of ions in the area of the quasimolecular ion of 2 (formate adduct; m/z = 393 to 401) which is composed of labeled and randomly re-assembled fragments of [¹³C₄¹⁵N]-Asp. In contrast, administration of [¹³C₃¹⁵N]-β-Ala displays a distinct pattern of isotopomers consistent with the incorporation of an intact C₃-segment and the ¹⁵N of the fed [¹³C₃¹⁵N]-β-Ala (m/z = 397) into 1. The 3-NPA ester 2 comprises two contiguous units of [¹³C₃¹⁵N]-β-Ala as is obvious from the fragment at m/z = 401. Peaks arising at m/z = 396 or 400 most likely result from loss of the nitrogen atom during transamination or from incomplete labelling of the commercial [¹³C₃¹⁵N]-β-Ala. Since β-alanine can be sequestered or originate from essential amino acids such as Val, Thr, Met, or Ile,^29–31via propanoate as an intermediate, its origin was further addressed by feeding [¹³C₃]-propanoate and [¹³C₅¹⁵N]-valine (Table S1†). In both cases the distinct fragment pattern from the incorporation of an intact carbon skeleton of the administered precursors was maintained. In the case of [¹³C₃]-propanoate two fragments at m/z = 396 and 399 support incorporation of one intact propanoate moiety into 1 and up to two units into 2. The same pattern is observed after feeding of [¹³C₅¹⁵N]-valine, while the ¹⁵N of the precursor amino acid is lost. This loss of the nitrogen atom together with consecutive incorporation by later transamination can lead to either [M + 4]- and [M + 5]-peaks ([M + 7]- and [M + 8]-peaks respectively), when the nitrogen is incorporated into ¹³C-labelled precursors, or [M + 1]- and [M + 2]-peaks, if the labelled nitrogen is incorporated into natural unlabeled precursors.

Fig. 2 Representative mass spectra of compound 2 after LC separation of larval extracts (MeCN/H₂O, 1 : 1) from P. cochleariae after feeding on different diets for 10 d; diets consisted of B. rapa pekinensis leaves, impregnated with KH₂PO₄/K₂HPO₄ buffered solutions of the compounds given above; as a control only blank buffer was used.

The HR-MS analysis of hydrolytically cleaved free 3-NPA from 2 confirms these findings. Feeding of [¹³C₃¹⁵N]-β-Ala generates a molecular ion at m/z = 122.021471 (¹³C₃H₄¹⁵NO₄, calc. for 122.021681, [M − H]⁻; Fig. S4†). The carbon skeletons of [¹³C₄¹⁵N]-Thr, [¹³C₃¹⁵N]-Ala, and [¹³C₂]-malonate were not incorporated at all into either 1 or 2 (Table S1†).

To explore the probability of the incorporation (%, see Experimental) of plant-derived β-alanine versus the de novo synthesis of β-Ala from essential precursor amino acids,^29–31 defined amounts of [¹³C₄¹⁵N]-Asp, [¹³C₃]-propanoate, and [¹³C₃¹⁵N]-β-Ala were injected into the hemolymph of P. cochleariae larvae (see Experimental; Table S1†) and the products 1 and 2 were analyzed by mass spectrometry. In the case of Asp no significant incorporation into 1 or 2 was observed (0.019 ± 0.241%), while average values of 2.3 ± 1.5 and 17.4 ± 11.2% were determined for labelled propanoate and β-Ala, respectively. Altogether, these results indicate that aspartate catabolism plays no significant role in the biosynthesis of compounds 1 and 2 although Asp is abundantly present in food plants (Fig. S13†). Altogether, we conclude that 1 and 2 are produced from both, sequestered and de novo produced β-Ala from degradation of the appropriate essential amino acids present in the food plant.

To investigate the later steps of the metabolic route from β-alanine to the isoxazolinone glucoside 1 and to its 3-NPA ester 2, potential intermediates such as [1-¹³C¹⁵N]-3 and [1-¹³C¹⁵N]-4 were synthesized and injected into the larvae (Table S1†). Accordingly, a stepwise oxygenation at the nitrogen atom of β-alanine first produces (N-hydroxyamino)propanoic acid 3 and (N-hydroxyimino)propanoic acid 4 (Fig. 3) after elimination of water from the postulated and unstable N-dihydroxy precursor. Cyclization of 4 generates the isoxazolinone 5 that is condensed with activated α-UDP-glucose to the isoxazolinone glucoside 1. Evidence for this reaction was provided by ¹H NMR measurements after incubation of fat body samples of all three investigated species together with the substrates (Fig. S2†). The isoxazolinone glucoside 1 circulates in the hemolymph and serves as a platform for acylation with activated 3-NPA.

Fig. 3 Proposed biosynthesis of compounds 1 and 2 in Chrysomelina larvae.

Further oxidation of the geminal dihydroxy intermediate of β-Ala generates 3-NPA that is subsequently bound to the C(6′)-hydroxy group of the isoxazolinone glucoside 1. Activation of 3-NPA is achieved as a CoA-ester and requires ATP (Fig. S3†). The increase of the glucoside ester 2 in later stages of larval development is in line with a decrease of 1 suggesting a tight control of the individual steps of the biosynthesis of 1 (Fig. S6–S11†). A similar trend was observed for 1 and 2 in the hemolymph.¹ Only very small amounts of free 3-NPA were detected in fresh hemolymph samples.¹ Furthermore, neither free β-Ala nor other intermediates, such as 3 to 5 could be detected after silylation and GC-MS analysis of hemolymph samples or whole larval extracts.

Conclusion

Beetles produce 3-NPA- and the isoxazolinone-moiety from plant-derived β-alanine or by degradation of the appropriate amino acids such as L-Val via propanoate to β-Ala. The extent of these alternative routes most likely depends on the contents of the required amino acids in the food plants (Fig. S12 and S13†). Since aspartate is not a precursor of 1 or 2, this excludes a hidden contribution from the gut microbiome since the decarboxylation of aspartate to β-alanine is known from microbial metabolism.³² It is important to note that the oxidation products of β-alanine serve as precursors for both 3-NPA and the isoxazolinone 1. As the production of the isoxazolinone glucoside 1 during the very early larval stages precedes the formation of 3-NPA, most likely different oxidases are involved that are tightly regulated. The larval enzymes are still unknown, but show mechanistic similarities to recently described microbial enzymes.²⁸ The isoxazolinone glucoside 1 circulates in the hemolymph of the insect and serves as a platform for acylation with activated 3-NPA (as CoA ester) as was demonstrated by injection of labelled free 3-NPA into the hemolymph of the larvae, which was then rapidly bound¹ to the glucoside carrier 1. The steric and electronic features of N-glucoside prevent an export of this compound from the hemolymph into neighbouring tissue or the defensive secretion of the insects, although S- and O-glucosides, for example plant-derived salicin, are sequestered by the larvae and channeled via the hemolymph through the whole body into the glandular system for defense production. Both, the O- and the N-glucosides share the hemolymph as a common carrier medium, but only the natural O-glucosides and their synthetic S-analogs are allowed to pass the separating membranes.³³ Therefore, the isoxazolinone glucoside 1 has never been found outside the hemolymph of larval systems. This is different in adults, which secrete several 3-NPA esters of 1 on their elytra^15,34 when endangered by a predator. We assume that after ingestion of a larva, the 3-NPA esters of 1 are rapidly hydrolyzed in the gut of the predator leading to intoxication. In a living larva, release of free 3-NPA is cured by activation as a CoA-ester and re-esterification to the C(6′) of isoxazolinone glucoside.¹ The identification and cloning of the enzymes catalyzing the transformation of the amino group of β-alanine to the functionally relevant nitro group are the next and urgent steps to understand the underlying mechanisms and the regulation of defense production in leaf beetle larvae.

Experimental

Insect collection and rearing

The procedures were adapted from already described methods.¹Chrysomela populi was collected near Dornburg, Germany (latitude 51.015, longitude 11.64), on Populus canadensis. The beetles were propagated using a light/dark cycle of 16 h light and 8 h darkness (LD 16/8), at 18 ± 2 °C in light and 13 ± 2 °C in darkness. Gastrophysa viridula was collected in Jena (latitude 50.929, longitude 11.597). Phaedon cochleariae (F.) was reared on Brassica rapa subsp. pekinensis (B. rapa pekinensis) “Cantonner Witkrop” (Quedlinburger Saatgut, Quedlinburg, Germany) and Gastrophysa viridula was reared on Rumex obtusifolius in a Snijder chamber (Snijders Scientific, Tilburg, Netherlands) in a light/dark cycle of 16 h light and 8 h darkness (LD 16/8) and 13 °C/11 °C ± 1 °C.

Insect sample preparation

150 μl of MeCN/H₂O 1 : 1 were added to individual larvae in grinding tubes equipped with 2 steel beads (diameter/bead = 4.5 mm). The samples were ground with a geno grinder (1210 rpm, 1 min) at rt for each larva. Then the mixtures were centrifuged at 40 °C and 13 000 rcf for 30 min. 110 μl of the supernatant was transferred to a second tube. The samples were stored at −25 °C and vortexed for 15 s directly before analysis by HPLC/MS. All in vivo measurements are single-larva analyses. All replicates are biological replicates of individual larvae.

Insect dissection

The larvae were immersed in liquid nitrogen for 30 s. Then the fat body was isolated after cutting the cuticles of the larvae with micro scissors. The tissue was stored at −80 °C prior to use.

Statistical evaluation

The results of the treated larvae were compared to the results of larvae of the control groups, in order to determine the statistical significance of the difference of the mean values. First, the data were analyzed by the Shapiro–Wilk normality test. For normally distributed datasets, the t-test was applied. For differently distributed datasets, the Mann–Whitney rank sum test was applied. Statistical difference is defined by a confidence level of at least 95% (* ≙95% ≙0.05, ** ≙0.01, *** ≙0.001).

HPLC/MS analysis

The analysis of compounds 1 and 2 was done by modifying the procedure that appears in the literature.¹ Measurements were carried out on an Agilent HP1100 HPLC system equipped with an OH-endcapped RP-C18 column (RP-C18e), LiChroCART (250 × 4 mm, 5 μm; Merck KGaA, 64271, Darmstadt, Germany) connected to a Finnigan LTQ (Thermo Electron Corp., Dreieich, Germany) ion trap mass spectrometer operating in the APCI mode (vaporizer temperature: 500 °C, capillary temperature 300 °C). Standard compounds for identification were either purchased (Sigma-Aldrich (St Louis, MO, USA)) or synthesized. 2 to 5 μl of the sample volume was injected, depending on the larval size (up to 20 mg larval fresh weight: 5 μl; m > 20 mg: 2 μl). The following parameters were used: flow rate = 0.5 ml min⁻¹ at rt: 90% solvent A (H₂O + 0.1% v/v HCO₂H) and 10% solvent B (MeCN + 0.1% v/v HCO₂H) for 5 minutes, linear gradient to 100% solvent B in 5 min, then 100% B for 2 min, linear gradient to 10% B in 5 min and further elution with 10% B for 5 min. For identification and quantification, the signals of the formic acid adducts [M + HCO₂H − H]⁻ were analyzed (m/z 292 for 2-(β-D-glucopyranosyl)-3-isoxazolin-5-one (1) and m/z 393 for 2-[6′-(3′′-nitropropanoyl)-β-D-glucopyranosyl]-3-isoxazolin-5-one (2)). The column was washed for 20 h at 40 °C with 2-propanol/MeCN 1 : 1 and then equilibrated to H₂O/MeCN 9 : 1 prior to use.

GC/MS analysis

The measurement parameters were similar to the literature protocols.³⁵ 1 μl of each sample was injected at a split ratio of 1 : 25 into a GC/MS system equipped with an A 200S autosampler, a GC 2000 gas chromatograph, and a Voyager quadrupole mass spectrometer including a dynode/phosphor/photomultiplier detector (all ThermoQuest, Manchester, UK). Tris(perfluorobutyl)amine (CF43) was used as a reference gas for tuning. Mass spectra were recorded from m/z 50 to 622 at 0.53 s scan⁻¹ for trimethylsilylated samples (TMS). For quantifications, the parameters were as follows: an injection temperature of 230 °C was chosen, the interface temperature was adjusted to 250 °C, and the ion source temperature was 200 °C. Helium flow was 1.5 mL min⁻¹. After a 5 min solvent delay at 70 °C, the oven temperature was increased by 5 °C min⁻¹ to 140 °C, then by 40 °C min⁻¹ to 310 °C; the temperature was constant for 1 min, then cooled to 70 °C and equilibrated for 5 min. Ion trace integration was performed manually over the complete intensities of the signals.

NMR and HRMS analysis

NMR spectra were recorded using a Bruker-Spektrospin AVANCE 400 UltraShield spectrometer operating at 400 MHz (¹H) and 100 MHz (¹³C). Chemical shifts (δ) are quoted in parts per million (ppm) and are referenced to the signals of residual protonated solvents in ¹H spectra (CHCl₃ at δ 7.26 ppm; HDO at δ 4.79 ppm) and deuterated chloroform in ¹³C spectra (CDCl₃ at δ 77.16 ppm). Acetonitrile was added as a reference for ¹³C NMR spectra in D₂O (H₃CCN at δ 1.47 ppm).³⁶ The multiplicities are given as follows: s, singlet; d, doublet; t, triplet, dd, doublet of doublets; dt, doublet of triplets; q, quartet; dq, doublet of quartets; m, multiplet. High-resolution mass spectra were recorded on a Bruker Maxis UHR-qTOF mass spectrometer.

Syntheses

Modified literature protocols were used to synthesize [1′,2′,3′,4′,5′,6′-¹³C₆]-2-(β-D-glucopyranosyl)-3-isoxazolin-5-one [1′,2′,3′,4′,5′,6′-¹³C₆]-1,³⁷ [1′,2′,3′,4′,5′,6′-¹³C₆]-2-[6′-(3′′-nitropropanoyl)-β-D-glucopyranosyl]-3-isoxazolin-5-one [1′,2′,3′,4′,5′,6′-¹³C₆]-2,³⁸ 2,2,2-trichloroethyl-3-nitropropanoate (6),³⁸ isoxazolin-5(2H)-one (5),³⁹ [1-¹³C¹⁵N]-3-(hydroxyamino)propanoate (3)^18,40 and [1-¹³C¹⁵N]-3-(hydroxyimino)propanoate (4).³⁹ The details of the synthetic protocols as well as the analytical data are presented in the ESI (S5–S16).†

In vitro assays

To show the incorporation of isoxazolin-5-one 5 into compound 1, 10 mg of the isolated fat body tissue was suspended in 400 μl H₂O. In addition, one solution containing 2.6 mg of isoxazolin-5-one 5 and one solution containing 18.7 mg of commercial α-UDP-glucose each in 200 μl were prepared. Solutions of compound 5 and α-UDP-Glc were mixed and split again into two solutions of 200 μl. To one solution, 200 μl of the fat body suspension was added; to the residual solution, 200 μl of buffer (KH₂PO₄/K₂HPO₄, 100 mM) was added. After 1 d of incubation at 30 to 40 °C, 400 μl of D₂O was added to each solution, including the fat body suspension, after which the mixtures were centrifuged and analyzed by 1D ¹H NMR experiments (512 scans each).

The ATP/CoA-dependent incorporation of 3-NPA into compound 2 was shown according to procedures in the literature⁴¹ Solutions of ATP (c = 125 mM), CoA (c = 5 mM), 3-NPA (10.5 mM), compound 1 (10.5 mM) and the isolated fat body tissue (m = 30 mg) in 2 ml of buffer (Tris-base 50 mM, sucrose 250 mM, MgCl₂ 2 mM, 1 μl ml⁻¹ dithiothreitol solution, 10 μl ml⁻¹ protease inhibitor mix) were prepared. The fat body mixture was homogenized using a geno grinder (1200 rpm, 30 s). Then five mixtures with an individual volume of 1 ml were prepared from these solutions as follows: solution 1 containing ATP, CoA, 3-NPA, compound 1, fat body; solution 2 (CoA, 3-NPA, compound 1, fat body, buffer); solution 3 (ATP, CoA, 3-NPA, compound 1, buffer); solution 4 (ATP, 3-NPA, compound 1, fat body, buffer) and solution 5 (ATP, CoA, fat body, 2 × buffer). After 1 d of incubation at 30 °C, 200 μl was taken and centrifuged (13 000 rcf, 15 min), and the supernatant was directly analyzed by HPLC/MS.

In vivo injection experiments

The larvae were fixed with pincers manually upon ice under a light microscope. Then a dose of 20 to 40 nmol substance per mg larval fresh weight was injected with a thin glass capillary attached to a microinjector. Typically injection volumes of 200 nl containing solutions of compounds with a concentration of 0.5 mol l⁻¹ dissolved in potassium phosphate (KH₂PO₄/K₂HPO₄) or potassium carbonate (K₂CO₃) buffers were applied. After the total volume was injected, the glass capillary was not removed from each larva for 1 min to prevent direct bleeding. Then the larvae were kept in plastic beakers covered with cardboard with a piece of their host plant leaf (100 to 400 mg) to enable air exchange at rt unless noted otherwise. The injected larvae were incubated for 24 h before being extracted with MeCN/H₂O 1 : 1.

Feeding experiments

Whole leaves were impregnated with aqueous buffered (KH₂PO₄/K₂HPO₄, pH 7.4, 500 mmol l⁻¹ + 300 μl of acetone, for reduction of surface tension) solutions of the isotopic-labeled compounds using a brush and given to P. cochleariae (L1 and L2) as food. The larvae were extracted after 7 to 10 d of feeding. Freshly impregnated leaves were added two or three times. The concentrations of the isotope-labeled compounds were as follows: [¹³C₄¹⁵N]-aspartate (c = 100 mmol l⁻¹), [¹⁵N]-aspartate (c = 100 mmol l⁻¹), [4-¹³C]-aspartate (c = 100 mmol l⁻¹), [¹³C₄]-aspartate (c = 100 mmol l⁻¹), [1,3-¹³C₂]-malonate, [¹³C₃¹⁵N]-α-L-alanine (c = 100 mmol l⁻¹), [¹⁵N]-α-L-alanine (200 mmol l⁻¹), [¹³C₃¹⁵N]-β-alanine (c = 100 mmol l⁻¹), [¹³C₃]-propanoic acid (c = 100 mmol l⁻¹), [¹³C₅¹⁵N]-valine (200 mmol l⁻¹) and [¹³C₄¹⁵N]-threonine (200 mmol l⁻¹). An overview is presented in the ESI (Table S1†).

Quantification and identification of amino acids in B. rapa pekinensis

The samples were analyzed according to procedures modified from the literature. 200–1000 mg FW of B. rapa subsp. pekinensis leaves were cut, transferred into a 2 mL tube, and mixed with 100 μl of [¹³C₃, ¹⁵N]β-alanine (c = 0.6 mmol l⁻¹). The samples were ground by using a geno grinder (1200 rpm, 3 × 5 min) and shaken at 40–60 °C for 3 h. 1 mL of methanol was added, and the samples were centrifuged for 15 min at 13 000 rcf. The supernatant was pipetted into a screw-top glass tube, and 2.5 ml of MeCN was added. The tubes were equipped with a needle, and the solvents were removed in a desiccator under reduced pressure at rt. This procedure was repeated until the samples were completely dried. To each sample, N-methyl-N-trimethylsilyltrifluoroacetamide (MSTFA) was added, and the samples were shaken at 40 °C for 30 min. The clear solutions were directly analyzed by GC/MS. The peak areas of the heavy isotope signals corresponding to the standards and the areas of the normal isotopes were integrated. The ratio of the peak areas gave the molar content of the amino acid c_m,AA,leaf in nmol (mg fresh weight)⁻¹ according to eqn (1):m_leaf = fresh weight of the leaf in mg, n_AA = amount of amino acid in nmol, I_AA = area of the non-isotopic peak ([M + 0]) of the amino acid, c_standard = molar concentration of the added solution of the isotopically labeled amino acid standard in μmol μl⁻¹, V_standard = volume of added solution of the isotopically labeled amino acid standard in μl, and I_standard = area of the isotopic peak of the isotopically labeled amino acid standard.

Quantification of compounds 1 and 2

Solutions of synthetic [1′,2′,3′,4′,5′,6′-¹³C₆]-2-(β-D-glucopyranosyl)-3-isoxazolin-5-one [1′,2′,3′,4′,5′,6′-¹³C₆]-1 (c = 17.33 mmol l⁻¹, V = 10 μl) as well as [1′,2′,3′,4′,5′,6′-¹³C₆]-2-[6′-(3′′-nitropropanoyl)-β-D-glucopyranosyl]-3-isoxazolin-5-one [1′,2′,3′,4′,5′,6′-¹³C₆]-2 (c = 14.65 mmol l⁻¹, V = 10 μl) in MeCN/H₂O 1 : 1 were added to each larval extract (SIL-IS^42,43). The peak areas of the heavy isotope signals in the chromatogram (m/z 298 for compound 1, m/z 399 for compound 2) were compared to the peak areas of the normal isotopes (m/z 292 for compound 1, m/z 393 for comp. 2). The molar contents c_{m,analyte,larva} of compounds 1 and 2 in nmol (mg larval fresh weight)⁻¹ were calculated using eqn (2):m_larva = fresh body weight of the extracted larva in mg, n_analyte = amount of compound 1 or 2 in nmol, I_analyte = area of the non-isotopic peak ([M + 0]) of compound 1 or 2, c_standard = molar concentration of added solution of synthetic comp. [1′,2′,3′,4′,5′,6′-¹³C₆]-1 or [1′,2′,3′,4′,5′,6′-¹³C₆]-2 in μmol μl⁻¹, V_standard = volume of added solution of synthetic [1′,2′,3′,4′,5′,6′-¹³C₆]-1 or [1′,2′,3′,4′,5′,6′-¹³C₆]-2 in μl, and I_standard = area of the isotopic peak ([M + 6]) of comp. [1′,2′,3′,4′,5′,6′-¹³C₆]-1 or [1′,2′,3′,4′,5′,6′-¹³C₆]-2. The resulting values are presented in the ESI (ESI, Fig. S6–S11†). Compounds containing more than one 3-NPA moiety bound to the sugar residue of an isoxazolin-5-one glucoside were detected in secretions of adult leaf beetles.¹⁵ However, these components were not detected in whole Chrysomelina larvae extracts; thus it is clear that compound 2 is the only 3-NPA based pre-toxic compound found at the larval stage. Consequently, quantification of compounds 1 and 2 provides information about the total amount of isoxazolin-5-one and 3-NPA derivatives in Chrysomelina larvae.

Incorporation of injected compounds

To demonstrate the incorporation of the injected compounds had taken place, the areas of the isotopic peaks of compounds 1 and 2 were divided by the areas of the non-isotopic peaks. These ratios were compared to the ratios determined in the control groups. In order to determine the percentile C of the incorporation of the injected compounds in % eqn (3) was used:n_det = sum of amounts of detected labeled isoxazolin-5-one and 3-NPA moieties in compound 1 and 2 in nmol, n_inj = amount of injected labeled compound in nmol, I₁ peak area of labeled compound 1 (intensity of control peak is always subtracted; if 1 of n labeled atoms is incorporated, the value of I is divided by n; if 2 of n are incorporated I is divided by n and multiplied by 2 and so forth), I_M1 = area of the non-isotopic peak of compound 1 ([M_comp.1 + 0]), I₂ = area of the single labeled isotopic peak of comp. 2, I_M2 = area of the non-isotopic peak of comp. 2 ([M_comp.2 + 0]), I₃ = area of the double labeled isotopic peak of comp. 2, m_larva,end = fresh body weight of the larva after incubation, c_inj = molar concentration of the injected compound in nmol nl⁻¹, and V_inj = volume of the injected compound in nl. Thus, naturally occurring compounds 1 and 2 were used as internal standards within the same measurement. The ratios of isotopic versus non-isotopic peaks determined in the control groups were subtracted from the ratios determined in the treated groups.

Author contributions

T. B. and W. B. planned and designed the project and experiments. T. B. synthesized the compounds. T. B. performed injection and feeding experiments. T. B. carried out the in vitro experiments. T. B. prepared the samples. T. B. measured and analyzed all NMR spectra. T. B. and K. P. performed HPLC/MS measurements. T. B. performed GC-MS measurements. T. B. analyzed GC- and LC-mass spectra. T. B. analyzed the statistical data. T. B. and W. B. wrote the manuscript.

Conflict of interest

The authors declare no competing financial interest.

Acknowledgements

We thank Emily Wheeler for her editorial assistance. We thank Dr Maritta Kunert and Dr Antje Burse for their help collecting samples. The help of Angelika Berg and Anja David for rearing the beetles is also acknowledged. We acknowledge René R. Gretscher for artwork of the graphical abstract. This work was supported by the Max Planck Society.

Notes and references

1. G. Pauls, T. Becker, P. Rahfeld, R. R. Gretscher, C. Paetz, J. M. Pasteels, S. H. von Reuss, A. Burse and W. Boland, J. Chem. Ecol., 2016, 42, 240.
2. J. M. Pasteels, D. Daloze and M. Rowell-Rahier, Physiol. Entomol., 1986, 11, 29.
3. J. M. Pasteels, J. C. Braekman, D. Daloze and R. Ottinger, Tetrahedron, 1982, 38, 1891.
4. J. M. Pasteels, D. Daloze and M. Rowellrahier, Physiol. Entomol., 1986, 11, 29.
5. M. Rowell-Rahier and J. M. Pasteels, J. Chem. Ecol., 1986, 12, 1189.
6. P. Laurent, J.-C. Braekman, D. Daloze and J. Pasteels, Eur. J. Org. Chem., 2003, 2733.
7. P. Laurent, J.-C. Braekman and D. Daloze, in The Chemistry of Pheromones and Other Semiochemicals II, ed. S. Schulz, Springer, Berlin, Heidelberg, 2005, vol. 240, p. 167.
8. T. Randoux, J. C. Braekman, D. Daloze and J. M. Pasteels, Naturwissenschaften, 1991, 78, 313.
9. I. Murakoshi, F. Ikegami, F. Kato, J. Haginiwa, F. Lambein, L. Van Rompuy and R. Van Parijs, Phytochemistry, 1975, 14, 1269.
10. L. van Rompuy, F. Lambein, R. De Gussem and R. van Parijs, Biochem. Biophys. Res. Commun., 1974, 56, 199.
11. F. Ikegami, F. Lambein, Y. H. Kuo and I. Murakoshi, Phytochemistry, 1984, 23, 1567.
12. F. Lambein, L. Van Rompuy, A. De Bruyn and R. Van Parijs, Arch. Int. Physiol. Biochim., 1974, 82, 187.
13. A. Burse, S. Frick, S. Discher, K. Tolzin-Banasch, R. Kirsch, A. Strauss, M. Kunert and W. Boland, Phytochemistry, 2009, 70, 1899.
14. P. Rahfeld, W. Haeger, R. Kirsch, G. Pauls, T. Becker, E. Schulze, N. Wielsch, D. Wang, M. Groth, W. Brandt, W. Boland and A. Burse, Insect Biochem. Mol. Biol., 2015, 58, 28.
15. W. Sugeno and K. Matsuda, Appl. Entomol. Zool., 2002, 37, 191.
16. J. W. Hylin and H. Matsumoto, Arch. Biochem. Biophys., 1961, 93, 542.
17. R. L. Baxter, E. M. Abbot, S. L. Greenwood and I. J. Mcfarlane, J. Chem. Soc., Chem. Commun., 1985, 564.
18. R. L. Baxter, A. B. Hanley, H. W. S. Chan, S. L. Greenwood, E. M. Abbot, I. J. Mcfarlane and K. Milne, J. Chem. Soc., Perkin Trans. 1, 1992, 2495.
19. R. C. Anderson, W. Majak, M. A. Rassmussen, T. R. Callaway, R. C. Beier, D. J. Nisbet and M. J. Allison, J. Agric. Food Chem., 2005, 53, 2344.
20. L. S. Huang, G. Sun, D. Cobessi, A. C. Wang, J. T. Shen, E. Y. Tung, V. E. Anderson and E. A. Berry, J. Biol. Chem., 2006, 281, 5965.
21. T. A. Alston, L. Mela and H. J. Bright, Proc. Natl. Acad. Sci. U. S. A., 1977, 74, 3767.
22. C. Olsen, A. Rustad, F. Fonnum, R. E. Paulsen and B. Hassel, Brain Res., 1999, 850, 144.
23. M. C. Williams, Rev. Weed Sci., 1994, 6, 1.
24. K. Francis, C. Smitherman, S. F. Nishino, J. C. Spain and G. Gadda, IUBMB Life, 2013, 65, 759.
25. Y.-H. Kuo, F. Ikegami and F. Lambein, Phytochemistry, 1998, 49, 43.
26. F. Lambein and Y.-H. Kuo, Int. J. Toxicol., Occup. Environ. Health, 1993, 2, 90.
27. E. Candlish, L. J. La Croix and A. M. Unrau, Biochemistry, 1969, 8, 182.
28. R. Winkler and C. Hertweck, ChemBioChem, 2007, 8, 973.
29. D. Y. Boudko, J. Insect Physiol., 2012, 58, 433.
30. Y. Kaziro and S. Ochoa, in Adv. Enzymol. Relat. Areas Mol. Biol, John Wiley & Sons, Inc., 2006, p. 283.
31. P. A. Brindle, D. A. Schooley, L. W. Tsai and F. C. Baker, J. Biol. Chem., 1988, 263, 10653.
32. P. Spiteller, in Amino Acids, Peptides and Proteins in Organic Chemistry, ed. A. B. Hughes, WILEY VCH, 2009, vol. 1, p. 119.
33. J. Kuhn, E. M. Pettersson, B. K. Feld, A. Burse, A. Termonia, J. M. Pasteels and W. Boland, Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 13808.
34. J. M. Pasteels, A. Termonia, D. Daloze and D. M. Windsor, in Proceedings of the Fifth International Symposium on the Chrysomelidae, Iguacu, 2000, ed. D. G. Furth, Pensoft Publishers, 2003, vol. 21, p. 261.
35. O. Fiehn, J. Kopka, R. N. Trethewey and L. Willmitzer, Anal. Chem., 2000, 72, 3573.
36. H. E. Gottlieb, V. Kotlyar and A. Nudelman, J. Org. Chem., 1997, 62, 7512.
37. T. Becker, P. Kartikeya, C. Paetz, S. H. von Reuss and W. Boland, Org. Biomol. Chem., 2015, 13, 4025.
38. T. Becker, H. Görls, G. Pauls, R. Wedekind, M. Kai, S. H. von Reuss and W. Boland, J. Org. Chem., 2013, 78, 12779.
39. F. De Sarlo, G. Dini and P. Lacrimini, J. Chem. Soc. C, 1971, 86.
40. C. Song, S. Tapaneeyakorn, A. C. Murphy, C. Butts, A. Watts and C. L. Willis, J. Org. Chem., 2009, 74, 8980.
41. A. Novoselov, T. Becker, G. Pauls, S. H. von Reuss and W. Boland, Insect Biochem. Mol. Biol., 2015, 63, 97.
42. S. Arrivault, M. Guenther, S. C. Fry, M. M. F. F. Fuenfgeld, D. Veyel, T. Mettler-Altmann, M. Stitt and J. E. Lunn, Anal. Chem., 2015, 87, 6896.
43. B. K. Matuszewski, J. Chromatogr., B, 2006, 830, 293.

---

Footnote

† Electronic supplementary information (ESI) available. See DOI: 10.1039/c6ob00899b

---